Abstract
An increased arterial stiffness (AS) has been proposed as a likely mechanism for a reduced cardiac baroreflex sensitivity (BRS) and the associated increases in 24h blood pressure (BP) variability (BPV). Aim of the present study was to explore this issue in a group of 90 normotensive, non-obese, healthy adults (mean age 48±10 yrs, 50% F). Methods BRS was assessed by computer analysis of 10 min beat-to-beat BP and ECG recordings obtained in resting supine. The linear regression slope of spontaneous concomitant increases or decreases in systolic BP and RR interval were calculated, averaged and expressed as total slope of BRS (ms/mmHg). Simultaneous recordings of pulse waveform were obtained by means of a validated oscillometric device for ABPM (Mobil-O-Graph NG, IEM, Stolberg, Germany) with inbuilt transfer-function like method, and pulse wave velocity (PWV, m/s) calculated. BPV was assessed for systolic and diastolic BP as 24h standard deviation (SD), weighted 24h SD (wSD), daytime and night-time SD from 24h ABPM. Results In multiple linear regression analysis AS (assessed through PWV), had the strongest effect on BRS variation (beta:-0.50, p<0.0001), followed by HR and male sex. No significant effect was observed for age or MAP on BRS (See table). A similar independent analysis, showed a significant inverse relationship between BRS and daytime systolic BP SD (beta:-0,23; p=0.036) Conclusion: Our findings suggest that in normotensive, otherwise healthy adults, decreased BRS and, indirectly, the associated increased day-time systolic BPV might be largely explained by an increased AS, independently of age and BP levels.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 University of Milano-Bicocca, Department of Clinical Medicine and Prevention, Milan, Italy (GRID:grid.7563.7) (ISNI:0000 0001 2174 1754); Istituto Auxologico Italiano, Department of Cardiology, S. Luca Hospital, Milan, Italy (GRID:grid.418224.9) (ISNI:0000 0004 1757 9530)
2 SICOR, Corporación para Investigaciones Biologicas, Clinical and Research Center, Medellin, Colombia (GRID:grid.420237.0) (ISNI:0000 0004 0488 0949)
3 Istituto Auxologico Italiano, Department of Cardiology, S. Luca Hospital, Milan, Italy (GRID:grid.418224.9) (ISNI:0000 0004 1757 9530)





